jrnl1315

Publication Venue For

  • New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutans.  46:174-182. 2015
  • Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp..  37:377-379. 2011
  • Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.  34:494-496. 2009
  • Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.  21:574-577. 2003
  • In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials.  20:136-140. 2002
  • In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.  18:531-535. 2001
  • Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.  18:373-378. 2001
  • Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest.  9:215-218. 1998
  • In vitro activities of cefepime versus cefotaxime and ceftriaxone against penicillin-resistant Streptococcus pneumoniae determined by Etest.  9:137-138. 1997
  • Microbially-produced peptides having potential application to the prevention of dental caries.  9:95-105. 1997
  • Antiretroviral drug interactions.  5:73-83. 1995
  • Itraconazole for the treatment of histoplasmosis and blastomycosis.  5:219-225. 1995